Global Blood and Plasma Collections and Use 2023–2024: Trends, Regulations, and Market Insights
Dana Miloslavich, Director Of Research at The Marketing Research Bureau Inc, shared on LinkedIn:
“The Marketing Research Bureau is pleased to announce the completion of the following report:
GLOBAL BLOOD AND PLASMA COLLECTIONS AND USE – 2023/2024
This new MRB report presents a global overview of blood collections and an analysis of all the sources of plasma used for fractionation from over 85 countries.
Plasma collection regulations and the historical context for those regulations are detailed in many countries, including plasma recovered from whole blood donations, as well as source plasma collected by public/non-profit entities and private companies.
Today, most of the plasma for fractionation is collected in the United States, but high collection costs constitute a cause of concern for those markets that largely depend on U.S. plasma.
Therefore, a good understanding of the potential for sourcing plasma from outside the U.S. is essential for planning and forecasting. In addition, awareness of plasma volumes collected in each individual country helps to inform both its current self-sufficiency level and quantities of imported plasma proteins needed to address its domestic market needs.
In addition to data on plasma for fractionation and whole blood collections, quantitative information on other blood components is included for those countries where such figures could be accessed.
Presented data are based on an extensive survey conducted by MRB in over 85 countries in 2023 and 2024. In addition to 2024 full-year figures for plasma fractionation, the report provides historical data going back 10 or more years as available”
Read more here.
More insights on Hemostasis Today.
-
Oct 30, 2025, 12:12Laura Ceci Galanos Reflects on WSC 2025
-
Oct 30, 2025, 03:53Michael Makris on Biomarin's Decision to Divest Roctavian
-
Oct 29, 2025, 10:39UMR1011 Researchers at ECTH 2025
-
Oct 29, 2025, 07:09Hritvik Jain and Andrew Goldsweig Sharedrisk About the Risk of MACCE, AMI, and readmission in IBD patients undergoing PCI
-
Oct 29, 2025, 07:07Flora Peyvandi Shared an Article About Menstrual Bleeding and Bleeding Tendency in Dutch Adolescents
-
Oct 30, 2025, 05:14Umberto Pensato on Reperfusion Outcomes in Stroke
-
Oct 29, 2025, 07:18Osimertinib Has Transformed Lung Cancer Care — But at What Cost to the Heart?
-
Oct 29, 2025, 07:15From the Lab to Prague․ Our ECTH 2025 Experience
-
Oct 29, 2025, 07:13Amol Akhade: Happy To Share Our Paper Published In Lancet Oncology
-
Oct 29, 2025, 07:09Davide Capodanno: This Time It’s About the Timing of Complete Revascularization in ACS
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Oct 27, 2025, 09:19Mitra Najafi: Digital Storage Device - Specifically Designed and Developed to Store and Preserve PRP
-
Oct 30, 2025, 11:56Lucas de Vries Defends His PHD Combining Physics, Deep Learning and Medical Imaging
-
Oct 30, 2025, 03:50Laura Bouvet Receives the Young Investigator Award at ECTH 2025
-
Oct 29, 2025, 08:30ECTH 2025․ Advancing the Science of Thrombosis and Haemostasis Together
-
Oct 28, 2025, 06:59Wim van den Broek Attended ECTH in Prague
-
Oct 28, 2025, 06:46Alexandre Kauskot Attended ECTH in Prague